Citigroup Portfolio holdings
Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.04B |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$542M |
| 3 |
iShares Core US Aggregate Bond ETF
AGG
|
+$469M |
| 4 |
VanEck Gold Miners ETF
GDX
|
+$433M |
| 5 |
Microsoft
MSFT
|
+$300M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$749M |
| 2 |
BPL
Buckeye Partners, L.P.
BPL
|
+$447M |
| 3 |
Alibaba
BABA
|
+$274M |
| 4 |
Invesco Dorsey Wright Momentum ETF
PDP
|
+$273M |
| 5 |
iShares MSCI EAFE ETF
EFA
|
+$242M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 6.66% |
| 2 | Financials | 5.43% |
| 3 | Healthcare | 5.11% |
| 4 | Consumer Discretionary | 4.43% |
| 5 | Communication Services | 3.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NVRO
4351
CALL
DELISTED
NEVRO CORP.
NVRO
| $517K | ﹤0.01% |
4,400
+1,500
| +52% | +$149K |
|
|
ITCI
4352
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $517K | ﹤0.01% |
15,084
-572
| -4% | -$6.87K |
|
4353
Corbus Pharmaceuticals
CRBP
$165M
| $516K | ﹤0.01% |
3,150
+1,723
| +121% | +$255K |
|
4354
ProShares UltraPro QQQ
TQQQ
$34.6B
| $516K | ﹤0.01% |
47,696
-21,200
| -31% | -$193K |
|
4355
Cannae Holdings
CNNE
$655M
| $514K | ﹤0.01% |
13,820
-11,157
| -45% | -$367K |
|
4356
Eaton Vance Tax-Advantaged Dividend Income Fund
EVT
$2.13B
| $513K | ﹤0.01% |
20,086
+17,543
| +690% | +$436K |
|
|
ADSW
4357
DELISTED
Advanced Disposal Services Inc
ADSW
| $513K | ﹤0.01% |
15,615
-404,686
| -96% | -$13.3M |
|
4358
BlackRock Taxable Municipal Bond Trust
BBN
$978M
| $509K | ﹤0.01% |
20,924
-14,047
| -40% | -$337K |
|
4359
PUT
Chord Energy
CHRD
$7.84B
| $508K | ﹤0.01% |
155,700
-419,300
| -73% | -$1.2M |
|
4360
iShares Core MSCI Total International Stock ETF
IXUS
$58.7B
| $508K | ﹤0.01% |
8,210
+6,553
| +395% | +$393K |
|
4361
Tronox
TROX
$909M
| $508K | ﹤0.01% |
44,500
+7,428
| +20% | +$74.2K |
|
|
POLY
4362
DELISTED
Plantronics, Inc.
POLY
| $508K | ﹤0.01% |
18,573
-11,229
| -38% | -$338K |
|
|
OPB
4363
DELISTED
Opus Bank Common Stock
OPB
| $507K | ﹤0.01% |
19,608
+5,403
| +38% | +$134K |
|
4364
CALL
Frontline
FRO
$8.88B
| $505K | ﹤0.01% |
39,300
+18,000
| +85% | +$196K |
|
4365
The Greenbrier Companies
GBX
$1.54B
| $505K | ﹤0.01% |
15,560
-15,944
| -51% | -$477K |
|
|
ARR
4366
Armour Residential REIT
ARR
$2.31B
| $504K | ﹤0.01% |
5,645
-1,258
| -18% | -$108K |
|
4367
State Street SPDR Bloomberg International Corporate Bond ETF
IBND
$459M
| $504K | ﹤0.01% |
14,746
+12,932
| +713% | +$435K |
|
4368
CALL
Rithm Capital
RITM
$5.62B
| $504K | ﹤0.01% |
31,300
-43,100
| -58% | -$677K |
|
4369
Sibanye-Stillwater
SBSW
$6.33B
| $504K | ﹤0.01% |
50,799
+49,882
| +5,440% | +$386K |
|
|
CY
4370
CALL
DELISTED
Cypress Semiconductor
CY
| $504K | ﹤0.01% |
21,600
-11,600
| -35% | -$271K |
|
4371
BlackRock Enhanced Global Dividend Trust
BOE
$676M
| $503K | ﹤0.01% |
45,838
+36,385
| +385% | +$386K |
|
4372
Nomura Holdings
NMR
$28B
| $503K | ﹤0.01% |
97,405
+67,055
| +221% | +$324K |
|
4373
United Natural Foods
UNFI
$2.87B
| $502K | ﹤0.01% |
57,349
+283
| +0.5% | +$2.28K |
|
4374
Fate Therapeutics
FATE
$291M
| $501K | ﹤0.01% |
25,575
-62,110
| -71% | -$986K |
|
4375
WisdomTree US AI Enhanced Value Fund
AIVL
$431M
| $500K | ﹤0.01% |
5,408
+6
| +0.1% | +$535 |
|
Similar funds
Citigroup's Q4 2019 Portfolio in Review
As of Q4 2019, Citigroup held 8,009 positions worth $138B, up 9.5% from $126B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Citigroup's Q4 2019 filing shows 285 new, 3,874 increased, 2,887 reduced and 270 closed positions. Its largest new stake was Stanley Black & Decker, Inc.: 372,155 shares worth $40.5M. The largest sale was Celgene Corp, an estimated $749M.
By sector, the portfolio is most concentrated in Technology at 6.7% of assets, up from 6.2% a quarter earlier, followed by Financials and Healthcare.
- Citigroup's largest Q4 2019 buy was Stanley Black & Decker, Inc.: 372,155 shares worth $40.5M.
- Citigroup added most to Invesco QQQ Trust in Q4 2019, an estimated $1.04B increase.
- Citigroup's biggest Q4 2019 reduction was Alibaba, cutting an estimated $274M.
- Citigroup fully exited Celgene Corp in Q4 2019, selling an estimated $749M.
- Citigroup's ten largest holdings make up 18% of its $138B portfolio in Q4 2019.
- Citigroup opened 285 new positions and closed 270 in Q4 2019.
- Citigroup's portfolio value rose 9.5% quarter-over-quarter to $138B.
Based on Citigroup's 13F filing for Q4 2019, filed 12 Feb 2020.